1032900-25-6 色瑞替尼

色瑞替尼

英文名称:Ceritinib
CAS:

1032900-25-6

分子式:C28H36ClN5O3S
精选商品
  • 化合物简介
  • 基本信息
  • 编号系统
  • MSDS
  • 图谱

色瑞替尼简介

Ceritinib (INN, trade name Zykadia) is a drug for the treatment of a specific type of lung cancer. It is an anaplastic lymphoma kinase (ALK) inhibitor. It was developed by Novartis. It was approved in April 2014 by the Food and Drug Administration for the treatment of ALK-positive metastatic non-small cell lung cancer (NSCLC) in patients that failed treatment with crizotinib. It is a more effective, but more toxic, alternative to traditional platinum-based chemotherapies. Ceritinib was found at physiological concentrations to inhibit ALK, insulin-like growth factor 1 receptor (IGF-1R), and ROS1.

色瑞替尼基本信息

中文名称 色瑞替尼 英文名称 Ceritinib
中文别名

5-氯-N2-(2-异丙氧基-5-甲基-4-(哌啶-4-基)苯基)-N4-(2-(异丙基磺酰基)苯基)嘧啶-2,4-二胺;

查看更多中文别名
英文别名

LDK378; CS-1406; QC-5183; 5-chloro-N2-(2-isopropoxy-5-methyl-4-(piperidin-4-yl)phenyl)-N4-[2-(propane-2-sulfonyl)phenyl]pyrimidine-2,4-diamine; S7083,LDK 378; LDK 378; 5-chloro-2-N-(5-methyl-4-piperidin-4-yl-2-propan-2-yloxyphenyl)-4-N-(2-propan-2-ylsulfonylphenyl)pyrimidine-2,4-diamine; 5-chloro-N2-(2-isopropoxy-5-methyl-4-piperidin-4-ylphenyl)-N4-[2-(isopropylsulfonyl)phenyl]-pyrimidine-2,4-diamine; Ceritinib (LDK378); LDK378||LDK-378;

查看更多英文别名
CAS号 1032900-25-6 分子式 C28H36ClN5O3S
分子量 558.13500 精确质量 557.22300
PSA 116.85000 LOGP 7.26640

色瑞替尼编号系统

UNII K418KG2GET
SDS 1.0 中文 展开
SDS 1.0 英文 展开
1H NMR : Predict展开

核磁图谱 1H NMR : Predict

收起
查看更多
色瑞替尼
CAS号:1032900-25-6 分子式:C28H36ClN5O3S 分子量:558.13500

化工圈APP

二维码

微信公众号

二维码

购物车

不要让您的购物车空着哦,买试剂买原料
如果您已添加过宝贝,那就赶紧登录查看吧

投诉建议

  • 咨询类别
  • 问题描述
  • 联系人电话
  • 联系人